Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date30 Jun 2020 |
100 Clinical Results associated with Changbaishan Pharmaceutical (Bozhou) Industrial Park Co., Ltd.
0 Patents (Medical) associated with Changbaishan Pharmaceutical (Bozhou) Industrial Park Co., Ltd.
100 Deals associated with Changbaishan Pharmaceutical (Bozhou) Industrial Park Co., Ltd.
100 Translational Medicine associated with Changbaishan Pharmaceutical (Bozhou) Industrial Park Co., Ltd.